发明名称 ARFORMOTEROL AND TIOTROPIUM COMPOSITION AND METHOD FOR USE
摘要 PROBLEM TO BE SOLVED: To provide a composition and a method for preventing and/or treating and/or respiratory disorders.SOLUTION: A liquid, propellant-free pharmaceutical composition comprises: (a) tiotropium, or pharmaceutically acceptable salt, hydrate or solvate thereof, in an amount between about 5 μg to about 30 μg based on tiotropium; and (b) a formoterol component comprising arformoterol, or pharmaceutically acceptable salt, hydrate or solvate thereof, in an amount between about 6 μg to about 40 μg based on arformoterol. The tiotropium and formoterol component are dissolved together in a liquid carrier, and the formoterol component comprises less than about 10 wt.% of stereoisomers of formoterol other than arformoterol.
申请公布号 JP2014237666(A) 申请公布日期 2014.12.18
申请号 JP20140143813 申请日期 2014.07.14
申请人 SUNOVION PHARMACEUTICALS INC 发明人 HUANG HOLLY;ELIZABETH B GOODWIN;KENDYL M SCHAEFER;JOHN P HANRAHAN;WILLIAM T ANDREWS;PAUL MCGLYNN
分类号 A61K31/46;A61K9/08;A61K9/12;A61K31/167;A61K47/10;A61P11/06;A61P11/08;A61P43/00 主分类号 A61K31/46
代理机构 代理人
主权项
地址